logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tadaaki Nishikawa

the jikei university school of medicine
H指数:17
被引数:1,752

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vaginal high-intensity focused ultrasound in women with genitourinary syndrome of menopause: a prospective exploratory study

绝经后生殖泌尿综合征女性中的阴道高强度聚焦超声：一项前瞻性探索性研究

Sexual Medicine
IF2
2026-08-280
OAAI
Chie Nagata, MD, PhD, MPH; Asuka Morikawa, MD, PhD; Sho Takahashi, PhD; Kanae Matsuno, MD, PhD; Seika Nagae, MD; Suguru Odajima, MD, PhD; Keiko Nakajima, MD; Daito Noguchi, MD; Ayako Kawabata, MD, PhD; Tadaaki Nishikawa, MD, PhD; Masataka Takenaka, MD, PhD; Satoshi Yanagida, MD, PhD; Nozomu Yanaihara, MD, PhD; Aikou Okamoto, MD, PhD
Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis

中危风险宫颈癌的最佳辅助治疗策略：一项系统评价和荟萃分析

International Journal of Clinical Oncology
IF2.8
2026-04-210
OAAI
Akira Yokoi; Hiroko Machida; Mika Okazawa-Sakai; Koji Nishino; Hanae Nishino; Mizue Itoi; Takumi Mitamura; Fumiaki Isohashi; Keisuke Tsuchida; Haruya Saji; Satoe Fujiwara; Noriko Ii; Miho Watanabe; Tadaaki Nishikawa; Satoshi Nakagawa; Michiko Kodama; Shinya Sato; Kazuhiro Takehara; Tohru Morisada; Shin-ei Noda; Munetaka Takekuma; Hiroaki Kajiyama; Hideki Tokunaga; Tsukasa Baba; Yoichi Kobayashi; Aikou Okamoto
Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer

DUO-E研究结果的简明总结：在晚期子宫内膜癌患者中给予durvalumab，联合或不联合olaparib。

Future Oncology
IF2.6
2026-04-060
PRE
Shannon N. Westin; Kathleen Moore; Hye Sook Chon; Jung-Yun Lee; Jessica Thomes Pepin; Michael Sundborg; Ayelet Shai; Joseph de la Garza; Shin Nishio; Michael A. Gold; Ke Wang; Kristi McIntyre; Todd D. Tillmanns; Stephanie V. Blank; Ji-Hong Liu; Michael McCollum; Fernando Contreras Mejia; Tadaaki Nishikawa; Kathryn Pennington; Zoltan Novak; Andreia Cristina De Melou; Jalid Sehouli; Dagmara Klasa-Mazurkiewicz; Christos Papadimitriou; Marta Gil-Martin; Birute Brasiuniene; Conor Donnelly; Xiaochun Liu; Els Van Nieuwenhuysen; null
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907)

阿特朱单抗在晚期肺泡软组织肉瘤中的临床、免疫学及基因组学发现：一项II期试验（ALBERT试验/NCCH1907）

European Journal of Cancer
IF7.1
2025-11-110
PRE
Yuki Kojima; Keisuke Watanabe; Motoko Arakaki; Tadaaki Nishikawa; Yukari Hoshina; Kenta Anjo; Akihiro Hirakawa; Masahiko Ichimura; Makoto Endo; Ikuo Kudawara; Masanobu Takahashi; Genki Okumura; Shohei Koyama; Akihiko Yoshida; Kouya Shiraishi; Hitoshi Ichikawa; Kan Yonemori
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling

建立一套全面的病人来源异种移植模型用于高级别子宫内膜癌：分子亚型、基因改变和治疗方法靶点分析

NEOPLASIA
IF7.7
2025-06-010
PRE
Sato, Sho; Yagishita, Shigehiro; Yoshida, Hiroshi; Shintani, Daisuke; Ogasawara, Aiko; Nishikawa, Tadaaki; Yasuda, Masanori; Furuuchi, Keiji; Uenaka, Toshimitsu; Hamada, Akinobu
Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab As First-Line Treatment For Endometrial Cancer: Patient-Reported Outcomes In The DUO-E/GOG-3041/ENGOT-EN10 Intent-To-Treat And Mismatch Repair Deficient Populations

度伐利尤单抗联合卡铂/紫杉醇后序贯度伐利尤单抗治疗子宫内膜癌的一线治疗：DUO-E/GOG-3041/ENGOT-EN10研究中的意向性治疗人群和错配修复缺陷人群的患者报告结局

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-02-010
PRE
Meyer, Larissa A.; Westin, Shannon N.; Messing, Mark; Hartenbach, Ellen; Carney, Michael; Bradley, William; Sobol, Urszula; Depasquale, Stephen; Agyemang-Prempeh, Kofi; Gil-Martin, Marta; Zagouri, Flora; Bodnar, Lubomir; Palmeiro, Daniela Neves; Wu, Xiaohua; Otero, Marco Antonio Torregroza; Nishikawa, Tadaaki; Kim, Jae-Weon; Donnelly, Conor; Jethoo, Gordhan; Van Nieuwenhuysen, Els
Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab Plus Olaparib As First-Line Treatment For Endometrial Cancer: Patient-Reported Outcomes In The DUO-E/GOG-3041/ENGOT-EN10 Intent-To-Treat And Mismatch Repair Proficient Populations

度伐利尤单抗联合卡铂/紫杉醇后接度伐利尤单抗联合奥拉帕利作为子宫内膜癌的一线治疗：DUO-E/GOG-3041/ENGOT-EN10研究的全分析集和错配修复功能正常人群的患者报告结局

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-02-010
PRE
Van Nieuwenhuysen, Els; Meyer, Larissa; Lucci, Joseph; Berman, Tara; Woliver, Thomas; Gordinier, Mary E.; Burke, James; Mchale, Michael; Galvez-Montosa, Fernando; Zagouri, Flora; Grisan, Karin; Sehouli, Jalid; Palmeiro, Daniela Neves; Wang, Wuliang; Otero, Marco Antonio Torregroza; Nishikawa, Tadaaki; Kim, Jae-Weon; Donnelly, Conor; Rychlik, Greg; Westin, Shannon N.
Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab With/Without Olaparib In Endometrial Cancer: Exploratory Analyses Of Histology, Biomarker Heterogeneity And Efficacy In The DUO-E Mismatch Repair Proficient Subpopulation

Durvalumab联合卡铂/紫杉醇后序贯Durvalumab联合或不联合奥拉帕利在子宫内膜癌中的探索性分析：DUO-E研究错配修复 proficient 亚人群的组织学、生物标志物异质性和疗效分析

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-02-010
PRE
Westin, Shannon N.; Moore, Kathleen; Chon, Hye Sook; Pepin, Jessica Thomes; Salinas, Erin A.; Starks, David; Disilvestro, Paul A.; Slomovitz, Brian; Vettus, Elen; Galvez, Fernando; Agyemang-Prempeh, Kofi; Zagouri, Flora; Kim, Jae-Weon; Gao, Qinglei; Contreras-Mejia, Fernando; Melo, Andreia Cristina De; Nishikawa, Tadaaki; Kowgie, Matthew; Iyer, Sonia; Van Nieuwenhuysen, Els
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine

eribulin或卡培他滨治疗HER2-null和HER2-low晚期乳腺癌的临床病理和预后特征

BREAST CANCER
IF2.9
2024-08-142
OAAI
Kitadai, Rui; Shimoi, Tatsunori; Yazaki, Shu; Okuma, Hitomi Sumiyoshi; Hoshino, Mai; Ito, Munehiro; Saito, Ayumi; Kita, Shosuke; Kojima, Yuki; Nishikawa, Tadaaki; Sudo, Kazuki; Noguchi, Emi; Fujiwara, Yasuhiro; Yoshida, Masayuki; Yonemori, Kan

研究方向

暂未获取到该数据
K
Kan Yonemori
H 指数:48论文数:1,048被引数:1.0万
T
Tatsunori Shimoi
H 指数:21论文数:358被引数:2,485
K
Kazuki Sudo
H 指数:29论文数:491被引数:3,020
Y
Yuki Kojima
H 指数:20论文数:350被引数:1,500
E
Emi Noguchi
H 指数:17论文数:133被引数:1,079
H
Hitomi Sumiyoshi Okuma
H 指数:14论文数:260被引数:575
H
Hiroshi Yoshida
H 指数:53论文数:1,016被引数:1.2万
A
Ayumi Saito
H 指数:14论文数:94被引数:538
Y
Yasuhiro Fujiwara
H 指数:65论文数:973被引数:1.7万
S
Shu Yazaki
H 指数:6论文数:93被引数:114